MSI Financial Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
SAM
TCM
LTFS
MSI Financial Services's PBE Position: Q4 2016 in Review
MSI Financial Services reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 13% in Q4 2016, selling an estimated $62.6K and leaving 10,329 shares worth $401K. The position accounts for 0.01% of the portfolio, ranked #787.
MSI Financial Services first reported a position in PBE in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.59M in Q4 2015. 68 funds tracked by Wall St. Rank hold PBE as of Q4 2016.
- MSI Financial Services held 10,329 shares of Invesco Biotechnology & Genome ETF worth $401K as of Q4 2016.
- MSI Financial Services sold 1,550 Invesco Biotechnology & Genome ETF shares in Q4 2016, an estimated $62.6K.
- Invesco Biotechnology & Genome ETF made up 0.01% of MSI Financial Services's portfolio in Q4 2016, its #787 holding.
- MSI Financial Services first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 15 quarters since.
- MSI Financial Services's Invesco Biotechnology & Genome ETF position peaked at $1.59M in Q4 2015.
- 68 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2016.
Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.